Study guide

5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

Key Takeaways Explain This Topic AI

Peak Expiratory Flow Rate (PEFR) represents the maximal flow achieved during an explosive exhalation starting from full TLC, primarily evaluating large airway caliber and respiratory effort.

Maximum Voluntary Ventilation (MVV) is measured over a 12-to-15 second rapid panting protocol at a frequency of 90 to 110 breaths per minute, extrapolated to L/min to assess total neuromuscular and mechanical ventilatory capacity.

The internal validity of an MVV maneuver is verified using the formula MVV ≈ FEV1 × 35 to 40; a measured MVV significantly below FEV1 × 35 indicates submaximal patient effort, muscle weakness, or upper airway obstruction.

Obstructive lung disease produces a classic 'scooped-out' (concave) expiratory flow-volume loop limb due to reduced mid-expiratory flows (FEF25-75%), whereas restrictive lung disease yields a narrow, tall 'witch's hat' configuration with reduced FVC and preserved flow rates.

Upper airway obstructions alter loop symmetry: variable intrathoracic obstruction flattens the expiratory limb, variable extrathoracic obstruction flattens the inspiratory limb, and fixed obstruction flattens both limbs into a rectangular box shape.

Last updated: August 2026

5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

Beyond basic FVC and FEV1 measurements, comprehensive pulmonary diagnostic evaluation includes specialized dynamic maneuvers and graphic waveform analysis. Peak Expiratory Flow Rate (PEFR) , Maximum Voluntary Ventilation (MVV) , and Flow-Volume Loop (FVL) graphic morphology provide crucial insights into large airway resistance, respiratory muscle endurance, chest wall mechanics, and upper airway obstructions.

This section reviews PEFR clinical utility, MVV testing protocols and mathematical validation formulas, and graphic analysis of flow-volume loop patterns encountered on the NBRC CPFT examination.

Peak Expiratory Flow Rate (PEFR)

The Peak Expiratory Flow Rate (PEFR) is the maximum flow rate achieved during a forced expiratory maneuver starting from full inspiration (TLC). Measured in liters per second ( L/sec \text{L/sec} L/sec ) on laboratory spirometers or liters per minute ( L/min \text{L/min} L/min ) on handheld peak flow meters, PEFR reflects the caliber of large, central airways and the strength of expiratory muscles.

Clinical Utility and Asthma Action Plans

PEFR is widely utilized in outpatient monitoring of asthma severity, response to bronchodilator therapy, and detection of occupational asthma. Patients monitor their personal best PEFR using a traffic-light zone system:

Green Zone (80%–100% of Personal Best): Good control; continue baseline maintenance medications.

Yellow Zone (50%–80% of Personal Best): Caution; indicates acute airway narrowing or asthma exacerbation; step up quick-relief bronchodilator therapy as prescribed.

Red Zone (< 50% of Personal Best): Medical emergency; severe airway obstruction; administer immediate short-acting bronchodilator and seek emergency medical evaluation.

Measurement Technique

PEFR must be measured from a position of full inspiration (TLC) with zero hesitation before blasting air out into the device. The technologist records the highest value from 3 acceptable attempts . On laboratory spirometry, an abnormally low PEFR with a preserved FEV1 indicates submaximal initial expiratory effort or upper airway obstruction.

Maximum Voluntary Ventilation (MVV)

The Maximum Voluntary Ventilation (MVV) maneuver evaluates the overall function of the respiratory system, including respiratory muscle strength, lung and chest wall compliance, airway resistance, and ventilatory control mechanisms.

Indications

MVV testing is indicated for pre-operative evaluation of patients undergoing thoracic or upper abdominal surgery, assessment of disability/occupational capacity, evaluation of neuromuscular diseases (e.g., amyotrophic lateral sclerosis, myasthenia gravis), and validation of cardiopulmonary exercise test (CPET) performance. Volume (L)

  • ^
  • 3.0| /\ /\ /\ /\ /\ /\ /\ <-- Rapid panting (~50% VC)
  • 2.0| / \/ \/ \/ \/ \/ \/ \
  • 1.0| / \ / \ / \ / \
  • 0.0|--+-----+------+------+------+-----> Time (12-15 seconds)
  • Step-by-Step MVV Testing Protocol

Positioning: Patient seated securely in an arm-supported chair with nose clip applied.

Instruction: The patient is instructed to breathe as deeply and rapidly as possible for a duration of 12 to 15 seconds .

Breathing Rate and Volume: Target breathing frequency must be 90 to 110 breaths per minute (bpm) (1.5 to 2.0 Hz), with a tidal volume equal to approximately 50% of Vital Capacity .

Extrapolation Formula: The total volume accumulated over the 12-second period is multiplied by 5 (or volume over 15 seconds multiplied by 4) to report MVV in liters per minute ( L/min \text{L/min} L/min BTPS): MVV (L/min) = Accumulated Volume in 12 sec × 5 \text{MVV (L/min)} = \text{Accumulated Volume in 12 sec} \times 5 MVV (L/min) = Accumulated Volume in 12 sec × 5

Quality Control and Validation Formula

A vital CPFT exam concept is verifying whether an MVV effort is internally valid relative to the patient's spirometry results. In individuals with normal lung function or uniform obstruction, MVV can be estimated using FEV1: Estimated MVV = FEV1 × 35 to 40 \text{Estimated MVV} = \text{FEV1} \times 35 \text{ to } 40 Estimated MVV = FEV1 × 35 to 40

Valid Effort: Measured MVV falls within FEV1 × 35 \text{FEV1} \times 35 FEV1 × 35 to FEV1 × 40 \text{FEV1} \times 40 FEV1 × 40 .

Submaximal Effort / Neuromuscular Deficit: Measured MVV is < FEV1 × 35 < \text{FEV1} \times 35 < FEV1 × 35 . This discrepancy alerts the technologist to submaximal effort, poor patient coordination, fatigue, or localized upper airway / respiratory muscle weakness.

Underestimated FEV1: Measured MVV is > FEV1 × 40 > \text{FEV1} \times 40 > FEV1 × 40 , suggesting that the patient gave incomplete effort during prior FVC testing.

Safety Considerations

Because MVV causes acute hypocapnia due to hyperventilation, patients may experience lightheadedness, dizziness, paresthesias, or syncope. Rest periods of at least 2–3 minutes must separate repeat trials, and testing should not exceed 2 acceptable trials.

Flow-Volume Loop (FVL) Graphic Morphology

A Flow-Volume Loop plots airflow on the vertical axis (y-axis, in L/sec) against volume on the horizontal axis (x-axis, in Liters). Expiratory flow is plotted above the zero-flow line, and inspiratory flow is plotted below. Flow (L/sec) [Expiratory]

  • ^
  • 10 | /\
  • 8 | / \
  • 6 | / \ <-- Normal Expiratory Curve
  • 4 | / \
  • 2 | / \
  • 0 +--+----------+----> Volume (L)
  • 2 | \ /
  • 4 | \______/ <-- Normal Inspiratory Curve
  • v
  • [Inspiratory]
  • Diagnostic Patterns
  • 1. Normal Flow-Volume Loop

Expiratory Limb: Rapid rise to a sharp peak flow ( P E F R PEFR PEFR ), followed by a nearly linear descent back to Residual Volume.

Inspiratory Limb: Smooth, symmetrical, rounded curve reaching peak inspiratory flow at approximately 50% of vital capacity.

2. Obstructive Pattern (e.g., Asthma, COPD, Emphysema)

Expiratory Limb: Concave or "scooped-out" shape during mid-to-late expiration (coving). This coving reflects marked reduction in flow rates at lower lung volumes ( F E F 25 − 75 % FEF_{25-75\%} FE F 25 − 75% ​ ) caused by loss of elastic recoil and small airway collapse.

Loop Position: Shifted to the left along the volume axis due to hyperinflation (increased T L C TLC T L C and R V RV R V ).

3. Restrictive Pattern (e.g., Idiopathic Pulmonary Fibrosis, Chest Wall Deformity)

Overall Shape: Tall, narrow loop often referred to as a "witch's hat" configuration.

Expiratory Limb: Steep, linear descent with high peak flows relative to lung volume, but total volume ( F V C FVC F V C ) is severely reduced.

Loop Position: Shifted to the right along the volume axis due to reduced Total Lung Capacity.

4. Upper Airway Obstruction (UAO) Patterns

Upper airway lesions produce characteristic graphic loop truncations depending on whether the lesion is fixed or variable, and whether it lies inside or outside the thoracic cavity: Variable Intrathoracic Variable Extrathoracic Fixed Obstruction

  • Expiratory Flattening Inspiratory Flattening Both Limbs Flattened
  • +------+ +------+ +------+
  • | | (Flattened) / \ | | (Flattened)
  • |______/ |________| (Flattened) |______| (Flattened)

Variable Intrathoracic UAO (e.g., Tracheomalacia, Lower Tracheal Tumor):

Mechanism: During forced exhalation, positive intrathoracic pressure compresses the flexible airway lesion, flattening the expiratory limb .

Inspiratory Limb: Normal and rounded, because negative intrathoracic pressure expands the trachea during inspiration.

Variable Extrathoracic UAO (e.g., Vocal Cord Dysfunction/Paralysis, Subglottic Stenosis):

Mechanism: During forced inspiration, subatmospheric intraluminal pressure causes the extrathoracic lesion to collapse inward, flattening the inspiratory limb .

Expiratory Limb: Normal, because positive expiratory pressure pushes the lesion outward.

Fixed Upper Airway Obstruction (e.g., Fixed Tracheal Stenosis, Rigid Goiter):

Mechanism: A rigid, non-collapsible lesion restricts airflow equally during both phases of respiration.

Graphic Morphology: Flattening of BOTH expiratory and inspiratory limbs , producing a characteristic rectangular or box-like loop.

Graphic Comparison Summary Matrix

Diagnostic Pattern Expiratory Limb Appearance Inspiratory Limb Appearance Primary Flow / Volume Alterations Typical Clinical Causes

Normal Sharp PEFR; linear decline to RV Symmetrical rounded curve Normal FVC, FEV1, PEFR Healthy non-smoker

Obstructive Concave ("scooped-out") mid-expiration Preserved or slightly decreased Reduced FEV1/FVC, FEF25-75% COPD, Asthma, Emphysema

Restrictive Narrow, steep ("witch's hat") Symmetrical but narrow Reduced FVC and TLC; normal FEV1/FVC Pulmonary Fibrosis, Scoliosis

Variable Intrathoracic UAO Flattened / truncated Normal rounded curve Reduced PEFR; normal inspiratory flow Tracheomalacia, Carina lesion

Variable Extrathoracic UAO Normal curve Flattened / truncated Reduced Peak Inspiratory Flow (PIFR) Vocal cord paralysis / dysfunction

Fixed UAO Flattened / truncated Flattened / truncated Box-like loop; reduced PEFR and PIFR Tracheal stenosis, Fixed mass